Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2+ storage

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 346-353

  Abdallah, Yaser ^a   Gkatzoflia, Anna ^a   Gligorievski, Dragan ^a   Kasseckert, Sascha ^a   Euler, Gerhild ^a   Schlüter, Klaus Dieter ^a   Schäfer, Matthias ^a   Piper, Hans Michael ^a   Schäfer, Claudia ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Calcium; Cardiomyocytes; Insulin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM ION; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; KT 5823; N(G) METHYLARGININE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLAMBAN; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL HYPOXIA; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL HYPOXIA; CELL SIZE; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM;

EID: 33646038017     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.02.020     Document Type: Article

References (21)

1. Piper H.M., Abdallah Y., and Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61 (2004) 365-367
2. Garcia-Dorado D. Myocardial reperfusion injury: a new view. Cardiovasc Res 61 (Feb 15 2004) 363-364
3. Sodi-Pallares D., Testelli M., and Fishelder F. Efects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 9 (1962) 166-181
4. van der Horst I.C., Zijlstra F., van't Hof A.W., Doggen C.J., de Boer M.J., Suryapranata H., et al. Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 42 (2003) 792-795
5. Mehta S.R., Yusuf S., Diaz R., Zhu J., Pais P., Xavier D., et al. CREATE-ECLA trial group investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
6. Jonassen A.K., Sack M.N., Mjos O.D., and Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89 (2001) 1191-1198
7. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI 3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105 (2002) 1497-1502
8. Jonassen A.K., Brar B.K., Mjos O.D., Sack M.N., Latchman D.S., and Yellon D.M. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32 (2000) 757-764
9. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95 (2004) 230-232
10. Garcia-Dorado D., Theroux P., Duran J.M., Solares J., Alonso J., Sanz E., et al. Selective inhibition of the contractile apparatus: a new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 85 (1992) 1160-1174
11. Siegmund B., Schluter K.D., and Piper H.M. Calcium and the oxygen paradox. Cardiovasc Res 27 (1993) 1778-1783
12. Abdallah Y., Gkatzoflia A., Pieper H., Zoga E., Walther S., Kasseckert S., et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66 (2005) 123-131
13. 2+ exchanger. Am J Physiol 276 (1999) H1868-H1876
14. Siegmund B., Schlack W., Ladilov Y.V., Balser C., and Piper H.M. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 96 (1997) 4372-4379
15. Piper H.M., Probst I., Schwartz P., Hütter F.J., and Spiekermann P.G. Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 14 (1982) 397-412
16. Ventura-Clapier R., and Veksler V. Myocardial ischemic contracture, metabolites affect rigor tension development and stiffness. Circ Res 74 (1994) 920-929
17. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78 (1998) 921-947
18. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 99 (1999) 597-601
19. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 15 (2004) 372-385
20. Bell R.M., and Yellon D.M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol 41 (2003) 508-515
21. Bell R.M., and Yellon D.M. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol 35 (2003) 185-193